Global Bovine Mastitis Market Size to grow USD 2.42 Billion by 2030 | CAGR of 5.5%

Global Bovine Mastitis Market worth $2.42 billion by 2030

According to a research report published by Spherical Insights & Consulting, the Global Bovine Mastitis Market Size to grow from USD 1.50 billion in 2021 to USD 2.42 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period. Bovine mastitis is expected to become more common over the next few years, which is expected to help the market grow. According to research done at Cornell University's College of Veterinary Medicine, the number of cows worldwide with bovine mastitis can range from 0 to 200.

Browse key industry insights spread across 240 pages with 183 market data tables and figures & charts from the report "Global Bovine Mastitis Market Size, Share, and COVID-15.5 Impact Analysis By Type (Clinical and Sub-Clinical), By Product (Antibiotics, Surgery, Vaccines, Pain Killers, and Others), By Route of Administration (Intra-Mammary and Systemic), By Therapy (Lactating Period and Dry Period), By End Users (Hospitals, Veterinary Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030." in detail along with the table of contents https://www.sphericalinsights.com/reports/bovine-mastitis-market

View a detailed Table of Content here–

The COVID-19 pandemic has made an adverse impact on credit portfolios. There has been an unprecedented rise in unemployment and disruption in economic activity, putting a strain on the solvency of customers and companies. Central banks have taken a proactive approach by injecting liquidity into the market by lowering interest rates and asset purchase programs. Managing and monitoring credit, market, liquidity, and operational risk across financial markets were hard enough with ongoing geopolitical tensions, international trade wars, and the occasional hurricanes and earthquakes. The current pandemic has forced chief risk officers and their teams to recalibrate old assumptions and models used to manage and monitor risk. COVID-19’s global impact has shown that interconnectedness plays an important role in international cooperation. As a result, many governments started rushing toward identifying, evaluating, and procuring reliable solutions powered by AI.

The clinical segment to account for the largest market size during the forecast period

 Based on type, the bovine mastitis market is categorized into Clinical and Sub-Clinical. The clinical segment to account for the largest market size during the forecast period. The increase in the dairy herd's size is one reason the sector is growing. Over the forecast period, the market is also expected to be driven by a rise in the number of cases of clinical mastitis in dairy cow farms.

The intra-mammary segment to hold a higher CAGR during the forecast period

 Based on the route of administration, the bovine mastitis market is categorized into Intra-Mammary and Systemic. The intra-mammary segment to hold a higher CAGR during the forecast period. In dairy cattle, mastitis is an infectious illness that has a high prevalence rate. An investigation on the efficacy of Angelica dahurica and Rheum officinale extracts, collectively referred to as Yi-Xiong-Tang (YXT), was carried out as a therapy for mastitis. A California mastitis test, also known as a CMT, was carried out, and the results showed that out of 179 lactating dairy cows, there were 67 udder quarters affected with mastitis. In order to treat the mastitis that was present in these 67 udder quarters, an intramammary infusion of YXT was administered twice a day for three days in a row. Clots, lactate dehydrogenase (LDH), total viable count of bacteria (TVC) in milk, interleukin-6 (IL-6), and interleukin-8 (IL-8) were among the mastitis markers that were evaluated both before and after the YXT therapy in order to determine how successful it was.

The dry period segment is to hold a higher CAGR during the forecast period.

Based on the therapy, the bovine mastitis market is categorized into Lactating Period and Dry Period. The dry period segment is to hold a higher CAGR during the forecast period. The increase in awareness and the rise in demand for effective treatment therapy enhances this segment.

North America is estimated to account for the highest market share in 2021.

The Global Bovine Mastitis Market has been segmented into five major regions:  North America, Europe, Asia-Pacific, South America, The Middle East and Africa. During the forecast period, the bovine mastitis market is not expected to change much. This is because intra-mammary infusion products are widely used to treat the infection, and leading players in the region offer a wide range of products to control the infection. In North America, the intra-mammary infusion is increasing at a rapid rate which is why this region has become dominant. Asia-Pacific to hold a higher CAGR during the forecast period.

Major vendors in the Global Bovine Mastitis Market include Zoetis, Merck & Co. Inc, Boehringer Ingelheim, Bayer AG, Elanco, Ceva, and West way health.

Related Report:

Wagyu Beef Market Size, Share, and Forecast 2030

https://www.sphericalinsights.com/reports/wagyu-beef-market

Functional Food Market Size, Share, and Forecast 2030

https://www.sphericalinsights.com/reports/functional-food-market

Contact Us: https://www.sphericalinsights.com/contact-us